The nation of Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (£272m) spanning five years because of the United States' request for confidential biological samples.
This rejection came to light after a official document dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
A government representative later stated that the US was demanding access to health data for scientific study and commercial gain but was not willing to guarantee the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged further dialogue to find a agreement agreeable to all parties so the country's vital HIV programme can proceed.
Wider Background
Zimbabwe's decision follows a comparable case in Kenya, where a court blocked a similar deal with the US following concerns were filed about the safety of citizens' medical information.
After resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing government-to-government agreements to boost transparency and responsibility.
Based on statements, Sixteen nations in Africa have so far agreed to similar agreements, representing over $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no corresponding assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," Mangwana explained.
"Effectively, our country would provide the basic resources for medical research without any certainty that the final treatments would be available to our citizens if a new pandemic arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting frameworks already set up via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing framework designed to manage future global health emergencies.
"This mechanism is intended to guarantee that when a country contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to develop them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage further discussions with our American counterparts on how future collaboration might be arranged in a way that honours the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that negotiations must proceed given that a large portion of the country's Aids initiatives relied on external financing.
"Where technical issues arise, such as those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," it added.
The situation underscores the continuing debate between accepting much-needed international aid and safeguarding local interests in an increasingly data-driven world.